clozapine 氯氮平

clozapine 
繁: 氯氮平
簡: 氯氮平

港大醫學院的跨學系研究團隊利用醫管局21年間的40萬份醫療大數據，進行全球首個針對高效抗精神病藥物「氯氮平」與血癌發病率關聯的分析研究，結果發現使用氯氮平導致血癌的風險極低，平均每一萬人用藥一年，僅增加不到6例血癌。

港大醫學院：抗精神病藥氯氮平導致血癌發病風險極低 (2025年1月2日)。明報新聞網，取自https://news.mingpao.com/ins/%E6%B8%AF%E8%81%9E/article/20250102/s00001/1735803757450

An inter-departmental research team at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has conducted the world’s first analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.

Study confirms clozapine safety with first big-data evidence on rare blood cancer cases (2025, Jan 2). Medical Xpress. Retrieved from https://medicalxpress.com/news/2025-01-clozapine-safety-big-evidence-rare.html#google_vignette